A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight

NCT06207877 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Cagrilintide
DRUG: Semaglutide
DRUG: Placebo

Sponsor

Novo Nordisk A/S